LONG-TERM OUTCOME AND ALLOANTIBODY PRODUCTION IN A NON-MYELOABLATIVE REGIMEN FOR INDUCTION OF RENAL ALLOGRAFT TOLERANCE1
Tatsuo Kawai(Harvard University), A. Benedict Cosimi(Harvard University), Masaaki Kimikawa, Shamila Mauiyyedi(Massachusetts General Hospital), Alain Poncelet(Cliniques Universitaires Saint-Luc), David H. Sachs, Svetlan Boskovic(Harvard University), Gregory Abrahamian(Harvard University), Han Zhou Hong, S L Wee(Harvard University), Amelia Bartholomew(University of Illinois Urbana-Champaign), Dicken S. C. Ko, Robert B. Colvin(Harvard University)
Cited by 170
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k